2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$18.53+$0.08 (+0.46%)
Price as of Jul 14, 2026 8:31 AM EDT- $581.3MMarket Cap
- 124.33%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$18.53+$0.08 (+0.46%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.44 | ||
Change | +$0.09 (+0.49%) | ||
Open | $18.30 | ||
High | $19.00 | ||
Low | $18.10 | ||
Previous Close | $18.35 | ||
Volume | 175,513 | ||
30-Day Average Volume | 628,050 | ||
1-Week Change | -6.06% | ||
1-Month Change | 72.18% | ||
1-Year Change | 124.33% | ||
3-Year Change | 21.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 31.5M | ||
Total Assets | $25.4M | ||
Market Cap | $581.3M | ||
Enterprise Value | $556.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$6.5M | ||
EBIT | -$6.0M | ||
EBITDA | -$6.0M | ||
Net Working Capital | $14.2M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -92 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 41 | ||
P/E | -71 | ||
PEG | -4 | ||
Price/Free Cash Flow | -89 | ||
Price/Operating Cash Flow | -89 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue